Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo - Wikidata - awgldk - TriplyDB

Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo

Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo

http://www.wikidata.org/entity/Q34062422

about

Oncosuppressive functions of decorin Antiangiogenic mechanisms and factors in breast cancer treatment Corneal gene therapy: basic science and translational perspective Fluid flow along venous adventitia in rabbits: is it a potential drainage system complementary to vascular circulations?Extracellular Matrix, a Hard Player in Angiogenesis Pivotal role for decorin in angiogenesis Gene therapy in the cornea: 2005--present.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.Nanotechnology and adeno-associated virus-based decorin gene therapy ameliorates peritoneal fibrosis Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.Decorin: a guardian from the matrix Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo.AAV Gene Therapy for MPS1-associated Corneal Blindness Inhibition of corneal neovascularization with the combination of bevacizumab and plasmid pigment epithelium-derived factor-synthetic amphiphile INTeraction-18 (p-PEDF-SAINT-18) vector in a rat corneal experimental angiogenesis model.Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: The role of decorin.Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling.Proteins of the corneal stroma: importance in visual function.Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.Novel Combination BMP7 and HGF Gene Therapy Instigates Selective Myofibroblast Apoptosis and Reduces Corneal Haze In Vivo.

P2860

Q26745697-2A823284-1CF6-41D9-90C2-DADF2E35D4ED Q26751226-0C66A669-B841-4336-B307-E111BDC3F1F2 Q27027504-9B9F2BEC-06A5-440F-B891-4DB4FAD35AD6 Q27332171-3E5B63F4-26F7-4BE2-B549-4FED2251DD9E Q28072886-018D302B-F376-48B8-A80E-592E048FF304 Q28085303-89584482-1394-4E5E-89A0-2111C9E51A14 Q30459643-FF20ED7C-8BCE-4D11-9901-6047231351DE Q33750977-9C576F38-C3D0-45E6-832C-BF614952E333 Q34295316-09B1F0C3-F0A3-4419-AAAB-5ABEDCB8C229 Q35773980-1350BD46-C041-411A-A333-75FE079342B4 Q36131541-06291C08-48BC-45B7-9405-A19DF4B8C219 Q36321993-8CF025E0-3103-4F57-A525-C41BAB32EE12 Q36602539-F0AEAAB9-E985-4657-BC8A-4E8B04B77285 Q36820584-0DBD2B60-559D-4C6E-A712-8E9912A306DF Q36857997-9D1AD7FF-48D3-4675-BBE3-64073DEE9569 Q37698825-4DB5B5C2-A0C3-4D2D-9152-31AE77889955 Q38746235-9F0542AF-0683-49E0-A6D8-93311164DF59 Q44905144-48EBD2DA-80B1-4F58-9320-8B53F3B5B707 Q47954026-C1E8CBD7-B9D8-4562-B83D-AEECE431034E Q50052813-A1C14381-2E22-4EAC-A478-69683459E39E Q52681170-37288649-8914-4D20-A12E-BAB6ADD68509

P2860

Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo

http://www.wikidata.org/entity/Q34062422

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeted decorin gene therapy ...... eal neovascularization in vivo

@ast

Targeted decorin gene therapy ...... eal neovascularization in vivo

@en

Targeted decorin gene therapy ...... eal neovascularization in vivo

@nl

type

label

Targeted decorin gene therapy ...... eal neovascularization in vivo

@ast

Targeted decorin gene therapy ...... eal neovascularization in vivo

@en

Targeted decorin gene therapy ...... eal neovascularization in vivo

@nl

prefLabel

Targeted decorin gene therapy ...... eal neovascularization in vivo

@ast

Targeted decorin gene therapy ...... eal neovascularization in vivo

@en

Targeted decorin gene therapy ...... eal neovascularization in vivo

@nl

P1433

Q34062422-57625D53-6D20-434B-8704-3E4D78E1EEE7

P1476

Q34062422-78010D41-1631-48DC-9C53-F55E0D28F741

P2093

Q34062422-48B00C1F-7BB7-4B16-9916-21071906E219

Q34062422-59C31E1C-3BB6-42CA-9E16-93386D258A78

Q34062422-D0548A60-130A-4976-A464-4F6CC38F6BC6

Q34062422-D2F1C686-4B96-435E-B1D9-005A21947308

Q34062422-F3DD8AC3-4CC7-403B-9DF7-5B1720D939BE

Q34062422-F665355F-5026-4E0B-97A8-959168B2D86B

P2860

Q34062422-004EC160-1BB3-47B5-9B87-B67BDBC91844

Q34062422-0333EEF4-EEA8-4F7C-9A5A-15F42ABE029A

Q34062422-10C8E7F3-7D76-45CD-94E1-BDAC8E31AB91

Q34062422-16ED6228-07EF-460E-9976-0052DDFDEF17

Q34062422-25744FB1-65BE-4524-A26E-D03D59276EA9

Q34062422-3157334B-743B-43BA-AFF9-0E87B652E0DC

Q34062422-34EB71FC-285E-4FE3-99A0-9784CEEEA8BA

Q34062422-3B23531E-500B-4199-92CE-EE4303E85381

Q34062422-51677334-9401-4947-BC0E-B096641FF665

Q34062422-5C0D1435-E482-488C-979C-C5241784F579

P304

Q34062422-02F409F0-4672-489C-B486-0132365845CD

P31

Q34062422-115C7D31-E528-4C45-B0C4-0231A768ED0A

P356

Q34062422-8BCC393B-C11E-4E76-BC30-662DEFDFA617

P407

Q34062422-E1974759-659F-4F68-A5B8-2C76634FB377

P433

Q34062422-F8F73A89-12C6-4E14-A5CA-60E701F73BEB

P478

Q34062422-8C5B052F-9C41-44C7-966D-23C940879257

P577

Q34062422-08C6C9DE-AE6C-40DB-8B8B-8C43353D79A6

P5875

Q34062422-7DB4505F-C08D-4456-AF6C-21909E0866CB

P698

Q34062422-AEFF0141-999B-48C2-9DCD-0A08793E0568

P921

Q34062422-8BA0678D-CE3B-43F8-848B-BDB899CCEBF3

Q34062422-A21C60D2-29CD-4237-9CFF-68F027D538DF

P932

Q34062422-2933F7AE-41EE-4631-BD02-A7D3D1E46555

P356

JOURNAL.PONE.0026432

P1433

P1476

Targeted decorin gene therapy ...... eal neovascularization in vivo

@en

P2093

Ajay Sharma

http://www.w3.org/2001/XMLSchema#string

Ashish Tandon

http://www.w3.org/2001/XMLSchema#string

Gregory S Schultz

http://www.w3.org/2001/XMLSchema#string

John W Cowden

http://www.w3.org/2001/XMLSchema#string

Jonathan C K Tovey

http://www.w3.org/2001/XMLSchema#string

Rajiv R Mohan

http://www.w3.org/2001/XMLSchema#string

P2860

Ocular drug delivery.

Gene therapy in the cornea.

Clinical and research applications of anterior segment optical coherence tomography - a review.

Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy

The role of small leucine-rich proteoglycans in collagen fibrillogenesis.

Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts

Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo

AAV serotype influences gene transfer in corneal stroma in vivo.

Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.

Vector delivery technique affects gene transfer in the cornea in vivo

P304

e26432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0026432

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51754055

http://www.w3.org/2001/XMLSchema#string

P698

22039486

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

3198476

http://www.w3.org/2001/XMLSchema#string